Ro vs Strut Health: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent researchHow we rank →

Strut Health beats Ro overall, scoring 8.4/10 vs 7.2/10. Choose Ro for users who want fda-approved brand-name glp-1 access includin. Choose Strut Health for users who prefer a needle-free oral semaglutide option at a .

A side-by-side comparison of Ro and Strut Health covering pricing, scores, medication types, insurance, and more to help you decide.

Ro

#44 of 48
7.2/10

One of the most recognized telehealth brands, now restructured: Ro Body membership ($149/mo ongoing or $74/mo annual prepay) is priced separately from medication. Added Foundayo (Eli Lilly's FDA-approved oral GLP-1 launched April 6, 2026) alongside Wegovy, Zepbound, Ozempic, and Mounjaro.

Visit Ro
Higher Rated

Strut Health

#4 of 48
8.4/10

Oral-focused GLP-1 provider offering needle-free semaglutide options for users who prefer pills over injections.

Visit Strut Health
FeatureRoStrut Health
Our Score7.2/108.4/10
Starting Price$149/mo$149/mo
Medication TypeBrandCompounded
Insurance AcceptedYesNo
Best ForUsers who want FDA-approved brand-name GLP-1 access including the new Foundayo (orforglipron) oral pill, with direct insurance billingUsers who prefer a needle-free oral semaglutide option at a reasonable price
Ranking#44#4

Pros & Cons Compared

Ro

Pros

  • +Carries Foundayo (orforglipron) — Eli Lilly's FDA-approved oral GLP-1 launched April 6, 2026 — at $149-299/mo via LillyDirect matching
  • +Direct insurance billing with major carriers — with coverage, Wegovy or Zepbound can cost $0-25/mo copay
  • +Ro Body membership: $39 first month, $149/mo ongoing, or $74/mo on annual prepay ($100/mo savings)
  • +Claims matched pricing with LillyDirect, NovoCare, and TrumpRx — some of the lowest cash brand prices available

Cons

  • Membership and medication are billed separately — readers need to add them together for the all-in monthly cost
  • Brand-name only — no compounded semaglutide or tirzepatide (compounded 'limited' footnote from prior years is not reliably offered now)
  • Without insurance, brand-name meds stack on top of the $149 membership ($199+ intro, $349+ ongoing for Wegovy injection)

Strut Health

Pros

  • +Specializes in oral compounded semaglutide — the go-to for patients who absolutely won't do injections
  • +$199/mo for a fully needle-free GLP-1 program including medication, consultations, and shipping
  • +Clear educational content about oral semaglutide absorption and how to maximize effectiveness
  • +Simple enrollment: online questionnaire, async provider review, medication shipped to your door

Cons

  • Oral compounded semaglutide only — no injectables, no tirzepatide, no brand-name options
  • Oral compounded semaglutide has lower bioavailability than injectable, meaning potentially less weight loss

Our Verdict

Strut Health edges out Ro with a score of 8.4/10 vs 7.2/10. Ro accepts insurance, which can significantly reduce your out-of-pocket costs. Choose Ro if you want: users who want fda-approved brand-name glp-1 access including the new foundayo (orforglipron) oral pill, with direct insurance billing. Choose Strut Health if you want: users who prefer a needle-free oral semaglutide option at a reasonable price.

Still undecided? Editor's #1 Overall Pick

Eden Health GLP-1

$249/mo · 8.9/10 · Both

If neither Ro nor Strut Health feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Eden Health GLP-1 — strongest balance of clinical oversight, transparent pricing, and verified availability.

Try Ro

Starting at $149/mo

Visit Ro

Try Strut Health

Starting at $149/mo

Visit Strut Health

Related comparisons

Other matchups readers comparing Ro or Strut Health tend to look at next.

Top Picks

Four programs our readers click through most.

Eden Health GLP-1

8.9/10
$249/mo·Brand & Compounded

Embody

7.3/10
$299/mo·Compounded

Gala

7.2/10
$149/mo·Brand & Compounded

Affiliate links — we earn a commission at no extra cost to you. Selection reflects what readers convert through, not editorial endorsement. Full ranking + methodology at glp1picks.com.